Heart Transplantation News and Research

RSS

A heart transplant is an operation in which the diseased heart in a person is replaced with a healthy heart from a deceased donor. Ninety percent of heart transplants are performed on patients with end-stage heart failure.

Heart failure is a condition in which the heart is damaged or weakened and can't pump enough blood to meet the body's needs. "End-stage" means the condition has become so severe that all treatments, other than heart transplant, have failed.

New generation of implanted devices help a failing heart function properly

A new generation of implanted devices that help a failing heart function properly is significantly more effective than the previous version, making these new devices an appropriate permanent therapy for many of the more than 5 million Americans who suffer from heart failure.

18 Nov 2009

NewYork-Presbyterian Hospital celebrates 25th anniversary of pediatric heart transplantation

NewYork-Presbyterian Morgan Stanley Children's Hospital is celebrating the 25th anniversary of pediatric heart transplantation. In 1984, the Hospital's surgeons performed the world's first successful heart transplant, giving the gift of life to a 4-year-old boy.

7 Nov 2009

25-year anniversary of the first neonatal cross-species heart transplantation to be celebrated

Monday, October 26, marks the 25-year anniversary of the first neonatal cross-species heart transplant in history. Dr. Leonard Bailey and a team of doctors at Loma Linda University Medical Center transplanted the heart of a baboon into an infant, born with uniformly lethal heart disease and known to the world as "Baby Fae," on October 26, 1984.

15 Oct 2009

Prompt diagnosis and treatment for otitis media benefits organ transplant recipients

Organ transplant recipients benefit significantly when they are monitored and receive prompt diagnosis and treatment for otitis media, a common inner ear infection.

5 Oct 2009

FDA approves the usage of Valcyte for preventing CMV disease in pediatric patients

Roche announced today that the U.S. Food and Drug Administration (FDA) has approved Valcyte(R) (valganciclovir hydrochloride) for the prevention of cytomegalovirus (CMV) disease in pediatric kidney and heart transplant patients (4 months to 16 years of age) at high risk of developing CMV disease.

31 Aug 2009

HeartWare achieves enrollment milestone under its ADVANCE Clinical Trial in the U.S

HeartWare International, Inc. (Nasdaq: HTWR - ASX: HIN) today announced that HeartWare has surpassed 50 implants in the United States under its ADVANCE Clinical Trial, marking an important early enrollment milestone.

21 Aug 2009

Adult bone marrow stem cells injected into skeletal muscle can repair heart tissue

University at Buffalo researchers have demonstrated for the first time that injecting adult bone marrow stem cells into skeletal muscle can repair cardiac tissue, reversing heart failure.

28 May 2009

Recently identified genetic heart disorder often deadly for young patients

A study that included young patients with a recently recognized rare type of cardiomyopathy (a disorder of the heart muscle) linked to a genetic mutation finds that progression of this disease may be rapid and often results in early death, according to a study in the March 25 issue of JAMA.

24 Mar 2009

Set of criteria help identify candidates for combined heart and kidney transplants

Researchers have identified a set of criteria that, when combined with a measure of kidney function, could help identify patients who are likely to receive a survival benefit from a combined heart and kidney transplant, according to a report in the March issue of Archives of Surgery.

16 Mar 2009

Heart failure linked to memory problems

Nearly half of patients with heart failure (HF) have problems with memory and other aspects of cognitive functioning, reports a new study published by Elsevier, in the February issue of Journal of Cardiac Failure.

8 Feb 2009

Receipt of ventricular assist devices associated with poor outcomes, high costs

Medicare patients who receive ventricular assist devices (a type of heart pump) have high rates of death, illness, prolonged hospital stays, with resulting high costs of care, according to a study in the November 26 issue of JAMA.

25 Nov 2008

Gender matching between donors and recipients important to survival in heart transplantation

Gender matching between donors and recipients is important to short- and long-term survival in heart transplantation, according to a retrospective study presented at the American Heart Association's Scientific Sessions 2008.

12 Nov 2008

Genetic test offers clues about cardiac hypertrophy in children

A mechanic uses diagnostic tests to determine why your engine is making strange sounds before lifting a wrench to fix the problem.

10 Apr 2008

Heart transplant standards set too low

Heart surgeons at Johns Hopkins have evidence to support further tightening rather than easing of standards used to designate hospitals that are best at performing heart transplants.

30 Jan 2008

National study will look at German-made heart pump for children needing heart transplants

Texas Children's Hospital has been named the national lead center for a 12-hospital, 36-month clinical trial of the German-manufactured pediatric heart pump called Berlin Heart EXCOR® Pediatric Ventricular Assist Device (VAD).

21 Jan 2008

Patient with AIDS finds heart-assit device is an option when transplant is not

Josh Bristow was in the late stages of heart failure when he came to the Emergency Department at Cedars-Sinai Medical Center on Aug. 25, 2007.

28 Dec 2007

Study of the post-transplant effects of alcohol use among lung donors

A recent study using an animal model of lung transplants shows that chronic alcohol consumption by the donor promotes scarring and airway injury after transplantation.

2 Dec 2007

Alcohol may promote scarring and airway injury after transplantation

A recent study using an animal model of lung transplants shows that chronic alcohol consumption by the donor promotes scarring and airway injury after transplantation.

27 Nov 2007

Lungs' pressure needn't threaten heart transplant survival

Heart surgeons at Johns Hopkins say people who need heart transplants can largely avoid transplant failure due to elevated blood pressure in their lungs with the help of proper drug treatment.

6 Nov 2007

Blood-incompatible infant heart transplants safe, may save more lives

ABO-incompatible heart transplantation (heart transplantation among non-compatible blood groups) can be safely performed in infants a year old or younger, researchers reported at the American Heart Association's Scientific Sessions 2007.